Mersana Therapeutics logo
Mersana Therapeutics MRSN
$ 2.05 3.54%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Mersana Therapeutics Total Current Liabilities 2011-2024 | MRSN

Annual Total Current Liabilities Mersana Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
63.6 M 91.5 M 47.5 M 30 M 24.1 M 69.4 M 31.9 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
91.5 M 24.1 M 51.2 M